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To the Editor: Mimivirus (Acanthamoeba polyphaga 
mimivirus), which was initially identified as a gram-pos-
itive parasitic bacterium, is the first member of the virus 
family Mimiviridae (1,2). Although mimivirus was initially 
isolated in the context of a human pneumonia outbreak, its 
pathogenicity to humans remains uncertain.
Mimivirus DNA was detected in a bronchoalveo-
lar lavage specimen from a 60-year-old comatose patient 
with hospital-acquired pneumonia (3) and isolated from a 
72-year-old woman with pneumonia (4). However, many 
studies that used a PCR detection method reported that 
mimivirus is a negligible cause of respiratory infections 
in humans (5–9). Furthermore, serologic evidence for this 
new virus was suggested as being caused by cross-reactivi-
ty to Francisella tularensis (10). To estimate the prevalence 
of mimivirus and its potential role in causing respiratory 
infections, we conducted a retrospective study by screening 
2 cohorts of patients in China for this virus.
Cohort 1 was composed of 2,304 children with acute 
lower respiratory tract infections who were hospitalized 
in Children’s Hospital of Chongqing Medical University 
(Chongqing, China), from whom nasopharyngeal aspirates 
were obtained during June 2011–July 2015. Patients ranged 
in age from 1 month to 16 years (median 15.0 months), and 
2,034 (88.3%) had pneumonia.
Cohort 2 was composed of 768 children (43 hospi-
talized patients and 725 outpatients) and 624 adults (440 
hospitalized patients and 184 outpatients) with acute 
lower or upper respiratory tract infections at 307 Hospital 
(Beijing, China), from whom throat swab specimens were 
obtained during January 2013–December 2015. Children 
ranged in age from 1 to 192 months (median 48.0 months), 
and 62 (8.1%) had pneumonia. Adults ranged in age 
from 17 to 95 years (median 52.9 years) and 401 (55.3%) 
had pneumonia.
Virus nucleic acids were extracted by using a QIAamp 
MinElute Virus Spin Kit (QIAGEN, Hilden, Germany). 
Mimivirus was detected by real-time reverse transcription 
PCR (RT-PCR) as described (4).
Of the 3,696 patients, only 1, a 6-month-old boy, had a 
positive real-time RT-PCR result (cycle threshold [Ct] 31) 
for mimivirus. This positive result was verified by using 2 
other RT-PCRs specific for the helicase and thiol oxidore-
ductase genes and a nested RT-PCR (3,6). The PCR spe-
cific for thiol oxidoreductase showed a positive result (Ct 
36). An independent retesting that was performed on this 
positive sample in the laboratory affiliated to PLA 307 
hospital was also positive. However, we could not amplify 
mimivirus sequences by using nested RT-PCR.
Samples from 3,696 patients were simultaneously 
screened for influenza virus; respiratory syncytial virus; 
parainfluenza virus types 1, 2, 3, and 4; metapneumovirus; 
human rhinovirus; human adenovirus; coronavirus, and hu-
man bocavirus by using PCR. All 11 of these respiratory 
viruses were detected at prevalences ranging from 0.35% 
to 21.98% (Table). Co-infections with 2 other respiratory 
pathogens, parainfluenza virus type 3 (Ct 30) and bocavirus 
(Ct 29), were detected in the mimivirus-positive patient. A 
sputum smear from this patient was negative for Mycobac-
teria tuberculosis, and other bacteria were not detected.
The mimivirus-positive patient had neonatal respira-
tory distress syndrome at birth and had been hospitalized 
6 times because of reoccurring respiratory tract infections 
before the episode during which mimivirus was detected. 
On July 24, 2013, he had a sudden onset of a slight fever 
(37.8°C), cough, and diarrhea (6–7 bowel movements/
day). After he was given supportive treatment, diarrhea 
improved, while fever and cough were aggravated; on-
set of larynx asthma was also recorded. He was admitted 
to the Respiratory Department of Children’s Hospital of 
Chongqing Medical University on July 28. Physical ex-
amination at admission showed lip cyanosis and 3 depres-
sion signs. Pulmonary computed tomography after hospi-
talization showed inflammation of the left upper lung and 
right lung. Laboratory investigations at admission showed 
a platelet count of 484 × 109/L, an erythrocyte count of 
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Table. Prevalence of 11 other viruses in 3,696 patients with 
respiratory diseases tested for infection with mimivirus, China 
Virus No. (%) patients 
Influenza virus 307 (8.31) 
Respiratory syncytial virus 812 (21.97) 
Parainfluenza virus type 1 275 (7.44) 
Parainfluenza virus type 2 13 (0.35) 
Parainfluenza virus type 3 253 (6.85) 
Parainfluenza virus type 4 38 (1.03) 
Metapneumovirus 85 (2.30) 
Human rhinovirus 543 (14.69) 
Human adenoviruses 123 (3.33) 
Coronavirus 79 (2.14) 
Human bocavirus 179 (4.84) 
 
4.28 × 109 cells/L, a hemoglobin level of 86 g/L, and a 
leukocyte count of 8.28 × 109 cells/L with 17% neutro-
phils and 78% lymphocytes.
The patient was given symptomatic supportive treat-
ment, methylprednisolone sodium succinate, and 5 g of 
γ-globulin. He was not given any antimicrobial drugs. On 
August 4, he was discharged from hospital after symptoms 
had resolved.
In conclusion, our results confirm that mimivirus is an 
unlikely cause of human respiratory infections in China, 
as reported in other countries (5–9). Sporadic detection of 
mimivirus in 1 child who was born with a compromised 
respiratory system and had numerous hospitalizations was 
most likely caused by colonization of the child with this 
virus during numerous hospitalizations and critical care 
stays. In addition, parainfluenza virus 3 and bocavirus were 
detected in the mimivirus-positive child. Because parain-
fluenza virus 3 causes pneumonia and bocavirus causes in-
fections with respiratory symptoms, particularly in children 
of his age, these 2 pathogens probably caused the illness in 
the child.
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To the Editor: Human adenoviruses (HAdVs) com-
prise 70 recognized genotypes (as of February 15, 2016; 
http://hadvwg.gmu.edu/) and are frequently associated 
with mild and acute upper respiratory tract infections, de-
pending on virus type and host immune status (1). HAdV 
type 55 (HAdV-55) has recently reemerged as a highly vir-
ulent pathogen, causing severe and sometimes fatal pneu-
monia among immunocompetent adults, particularly in 
Asia (2–4). Formerly known as HAdV-11a, HAdV-55 is a 
genotype resulting from recombination between HAdV-11 
and HAdV-14 (5). We report 2 cases of severe pneumonia 
associated with HAdV-55 infection in France.
In November 2014, two immunocompetent women, 
71 (patient A) and 36 (patient B) years of age, sought 
care 4 days apart at the emergency unit of the University 
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